Subclinical Hypothyroidism is an Independent Predictor of Adverse Cardiovascular Outcomes in Patients with Acute Decompensated Heart Failure
Tomohiro Hayashi(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Yasuo Sugano(keiyu Hospital), Akira Funada(National Cerebral and Cardiovascular Center), Satoshi Yasuda(Tohoku University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Makoto Amaki(National Cerebral and Cardiovascular Center), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Hiroyuki Takahama(Tohoku University)
Cited by 80
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755